Publication Date:
2021-02-19
Description:
In hemolytic disorders, erythrocyte lysis results in massive release of hemoglobin and, subsequently, toxic heme. Hemopexin is the major protective factor against heme toxicity in human blood and currently considered for therapeutic use. It has been widely accepted that hemopexin binds heme with extraordinarily high affinity of
Print ISSN:
1431-6730
Electronic ISSN:
1437-4315
Topics:
Biology
,
Chemistry and Pharmacology
Permalink